Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Nano beraprost sodium - LTT Bio-Pharma

Next Previous
Drug Profile

Nano beraprost sodium - LTT Bio-Pharma

Alternative Names: LT-2004; Nano-BPS

Latest Information Update: 28 Jul 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator LTT Bio-Pharma
  • Class 3-ring heterocyclic compounds; Alkynes; Antihypertensives; Antiplatelets; Benzofurans; Butyric acids; Cyclopentanes; Prostaglandins; Small molecules; Vasodilators
  • Mechanism of Action Cytokine inhibitors; Epoprostenol receptor agonists; G protein-coupled receptor agonists; Platelet aggregation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Pulmonary hypertension

Most Recent Events

  • 28 Jul 2024 No recent reports of development identified for research development in Pulmonary-hypertension in Japan
  • 11 Jun 2020 Nano beraprost sodium is available for licensing as of 11 Jun 2020. http://www.ltt.co.jp/english/partnership/indication/
  • 09 Jun 2020 Early research in Pulmonary hypertension in Japan (unspecified route), prior to June 2020 (LTT Bio-Pharma pipeline, June 2020)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top